there is no support for Alan

First 263 Last

Share
Profile

Follow
macnizel

441 Posts.

117

14/07/23

19:36

Post #: 68797564
Share

Originally posted by trevorm28: ↑

I think that Alan is a bit busy at the moment. Strategic Minerals PIC has it's AGM next week, 18 July in London.
What we sold them,

"In May 2016, the Company entered into an agreement with New Age Exploration
Limited and, in February 2017, acquired 50% of the Redmoor Tin/Tungsten
project in Cornwall, UK. The bulk of the funds from the Company's investment
were utilised to complete a drilling programme that year. The drilling
programme resulted in a significant upgrade of the resource. This was followed
in 2018 with a 12-hole 2018 drilling programme has now been completed and the
resource update that resulted was announced in February 2019. In March 2019,
the Company entered into arrangements to acquire the balance of the Redmoor
Tin/Tungsten project which was settled on 24 July 2019 by way of a vendor loan
which was fully repaid on 26 June 2020."

And in the Chairman's report,

"The Cornish mining revival continued to gather pace in 2022. We consider CRL
to represent a significant asset in this regional play and its recent
extension of arrangements provides the time to develop this fully to the best
benefit of shareholders. The global significance of the deposit at Redmoor
(inferred resource of 11.7mt at a tin equivalent (SnEq) of 1.17%) was further
reinforced, in July 2022, when both Tungsten and Tin were included in the UK
Critical Minerals List. This has opened the way for CRL to seek grant funding
for progressing the Redmoor project to pre-feasibility stage. There have
been encouraging recent developments in the US involving both defence
contractors having to source Tungsten supplies from non-Chinese/Russian
suppliers by 2026 and current indications that the US will deem the UK a
"domestic" supplier, thus providing access for UK projects to US government
funding."

And,

"Finally, I would like to acknowledge the support of our shareholders,
suppliers and other stakeholders and I look forward to your continued support
during 2023 and beyond.

Alan Broome AM

Chairman"

Expand

there is no support for Alan

NAE Price at posting: 0.6¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

AI stocks: What to expect in 2024-25

CTT

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

NWC

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

ATH

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

LRL

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

There are more pages in this discussion • 285 more messages in this thread...

First 263 Last

Add NAE (ASX) to my watchlist

(20min delay)
Last 0.4¢		Change 0.000(0.00%)		Mkt cap ! $7.175M

Open	High	Low	Value	Volume
0.4¢	0.4¢	0.4¢	$6.079K	1.519M

Buyers (Bids)

No.	Vol.	Price($)
3	1479783	0.4¢

Sellers (Offers)

Price($)	Vol.	No.
0.5¢	25327472	24

View Market Depth

No.	Vol.	Price($)
3	1479783	0.004
40	28339222	0.003
21	26914599	0.002
11	41400000	0.001
0	0	0.000

Price($)	Vol.	No.
0.005	25327472	24
0.006	9981130	9
0.007	5390733	5
0.008	3530010	6
0.009	1926139	14

Last trade - 11.28am 17/07/2024 (20 minute delay)

NAE (ASX) Chart

there is no support for Alan

AI stocks: What to expect in 2024-25

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

there is no support for Alan

Top Stories

AI stocks: What to expect in 2024-25

Cettire shares jump on FY24 revenue growth up 80% vs pcp – but stock still badly bruised

New World Resources inks complete PFS for Antler Copper Project in Arizona, USA

Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability

Labyrinth shares rocket by 219% on news of Comet Vale and Vivien gold project acquisitions

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News